Viewing Study NCT05209256


Ignite Creation Date: 2025-12-24 @ 11:31 PM
Ignite Modification Date: 2026-01-02 @ 12:00 AM
Study NCT ID: NCT05209256
Status: UNKNOWN
Last Update Posted: 2022-01-26
First Post: 2022-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC
Sponsor: The First Affiliated Hospital of Henan University of Science and Technology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module